STOCK TITAN

[8-K] SONO TEK CORP Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Sono-Tek Corporation reported via an 8-K that it issued a press release announcing an order for medical device coating systems valued at $2.8 million.

The disclosure was furnished under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure) and includes Exhibit 99.1, a press release dated October 13, 2025. The furnished information is not deemed filed under Section 18 of the Exchange Act.

Sono-Tek Corporation ha comunicato tramite un 8-K che ha emesso un comunicato stampa annunciante un ordine per sistemi di rivestimento per dispositivi medici del valore di 2,8 milioni di dollari.

La comunicazione è stata fornita ai sensi di Item 2.02 (Risultati operativi e stato patrimoniale) e Item 7.01 (Divulgazione Regulation FD) e include Exhibit 99.1, un comunicato stampa datato 13 ottobre 2025. Le informazioni fornite non sono considerate depositate ai sensi della Sezione 18 della Exchange Act.

Sono-Tek Corporation informó mediante un 8-K que emitió un comunicado de prensa anunciando un pedido para sistemas de recubrimiento de dispositivos médicos valorado en $2.8 millones.

La divulgación se proporcionó bajo Item 2.02 (Resultados de operaciones y situación financiera) y Item 7.01 (Divulgación Regulation FD) e incluye Exhibit 99.1, un comunicado de prensa fechado el 13 de octubre de 2025. La información proporcionada no se considera presentada conforme a la Sección 18 de la Ley de Intercambio.

Sono-Tek Corporation은 8-K를 통해 의료 기기 코팅 시스템 주문이 280만 달러의 가치임을 발표하는 보도자료를 발행했다고 보고했습니다.

해당 공시는 Item 2.02 (영업실적 및 재무상태) 및 Item 7.01 ( Regulation FD 공시) 하에 제공되었으며 Exhibit 99.1을 포함하고 있으며, 날짜는 2025년 10월 13일자 보도자료입니다. 제공된 정보는 Exchange Act 제18조에 따라 제출된 것으로 간주되지 않습니다.

Sono-Tek Corporation a déclaré par le biais d’un 8-K avoir publié un communiqué annonçant une commande pour des systèmes de revêtement pour dispositifs médicaux d’une valeur de 2,8 millions de dollars.

La divulgation a été fournie conformément à Item 2.02 (Résultats opérationnels et situation financière) et Item 7.01 (Divulgation Regulation FD) et comprend Exhibit 99.1, un communiqué de presse daté du 13 octobre 2025. Les informations fournies ne sont pas considérées comme déposées en vertu de la Section 18 du Exchange Act.

Sono-Tek Corporation berichtete gemäß einer 8-K, dass sie eine Pressemitteilung veröffentlicht habe, die eine Bestellung für Beschichtungsanlagen für Medizinprodukte im Wert von 2,8 Millionen US-Dollar ankündigt.

Die Offenlegung wurde unter Item 2.02 (Ergebnisse der Operationen und Finanzlage) und Item 7.01 (Regulation FD Offenlegung) bereitgestellt und enthält Exhibit 99.1, eine Pressemitteilung vom 13. Oktober 2025. Die offengelegten Informationen gelten nicht als gemäß Section 18 des Exchange Act eingereicht.

Sono-Tek Corporation أعلنت عبر 8-K أنها أصدرت بياناً صحفياً يعلن عن أمر لنُظم تغطية للأجهزة الطبية بقيمة 2.8 مليون دولار.

تم توفير الكشف وفقاً لـ Item 2.02 (نتائج العمليات والوضع المالي) و Item 7.01 (إفصاح Regulation FD) ويشمل Exhibit 99.1، بيان صحفي مؤرخ في 13 أكتوبر 2025. المعلومات التي تم توفيرها لا تعتبر مُقدمة وفق القسم 18 من قانون التبادل.

Sono-Tek Corporation 通过 8-K 报告发布了一份新闻稿,宣布一项价值 280万美元 的医疗设备涂层系统订单。

该披露是在 Item 2.02(经营结果与财务状况)和 Item 7.01(Regulation FD 披露)下提供的,并包括 Exhibit 99.1,日期为 2025 年 10 月 13 日的新闻稿。所提供的信息不被视为根据信托条款第 18 条提交。

Positive
  • None.
Negative
  • None.

Insights

Operationally positive: a disclosed $2.8 Million order signals tangible demand and near-term business activity, furnished via 8-K Items 2.02 and 7.01.

Sono-Tek Corporation reported an order for medical device coating systems valued at $2.8 Million on October 13, 2025. This is concrete commercial execution in the medical device segment, indicating active customer purchasing for its coating systems. The disclosure was furnished under Items 2.02 and 7.01 with an attached press release (Exhibit 99.1).

The company designated the information as "furnished," not "filed," which limits Section 18 liability and frames the update as informational rather than a full financial filing. While this is a single order disclosure, it reflects booked business tied to core products, which is operationally favorable.

Watch for follow-on disclosures that detail delivery status, revenue recognition within upcoming periods, and any related production or capacity updates in subsequent reports. The press release dated October 13, 2025 is the key source for specifics on the order scope and context.

Sono-Tek Corporation ha comunicato tramite un 8-K che ha emesso un comunicato stampa annunciante un ordine per sistemi di rivestimento per dispositivi medici del valore di 2,8 milioni di dollari.

La comunicazione è stata fornita ai sensi di Item 2.02 (Risultati operativi e stato patrimoniale) e Item 7.01 (Divulgazione Regulation FD) e include Exhibit 99.1, un comunicato stampa datato 13 ottobre 2025. Le informazioni fornite non sono considerate depositate ai sensi della Sezione 18 della Exchange Act.

Sono-Tek Corporation informó mediante un 8-K que emitió un comunicado de prensa anunciando un pedido para sistemas de recubrimiento de dispositivos médicos valorado en $2.8 millones.

La divulgación se proporcionó bajo Item 2.02 (Resultados de operaciones y situación financiera) y Item 7.01 (Divulgación Regulation FD) e incluye Exhibit 99.1, un comunicado de prensa fechado el 13 de octubre de 2025. La información proporcionada no se considera presentada conforme a la Sección 18 de la Ley de Intercambio.

Sono-Tek Corporation은 8-K를 통해 의료 기기 코팅 시스템 주문이 280만 달러의 가치임을 발표하는 보도자료를 발행했다고 보고했습니다.

해당 공시는 Item 2.02 (영업실적 및 재무상태) 및 Item 7.01 ( Regulation FD 공시) 하에 제공되었으며 Exhibit 99.1을 포함하고 있으며, 날짜는 2025년 10월 13일자 보도자료입니다. 제공된 정보는 Exchange Act 제18조에 따라 제출된 것으로 간주되지 않습니다.

Sono-Tek Corporation a déclaré par le biais d’un 8-K avoir publié un communiqué annonçant une commande pour des systèmes de revêtement pour dispositifs médicaux d’une valeur de 2,8 millions de dollars.

La divulgation a été fournie conformément à Item 2.02 (Résultats opérationnels et situation financière) et Item 7.01 (Divulgation Regulation FD) et comprend Exhibit 99.1, un communiqué de presse daté du 13 octobre 2025. Les informations fournies ne sont pas considérées comme déposées en vertu de la Section 18 du Exchange Act.

Sono-Tek Corporation berichtete gemäß einer 8-K, dass sie eine Pressemitteilung veröffentlicht habe, die eine Bestellung für Beschichtungsanlagen für Medizinprodukte im Wert von 2,8 Millionen US-Dollar ankündigt.

Die Offenlegung wurde unter Item 2.02 (Ergebnisse der Operationen und Finanzlage) und Item 7.01 (Regulation FD Offenlegung) bereitgestellt und enthält Exhibit 99.1, eine Pressemitteilung vom 13. Oktober 2025. Die offengelegten Informationen gelten nicht als gemäß Section 18 des Exchange Act eingereicht.

false 0000806172 SONO TEK CORP 0000806172 2025-10-13 2025-10-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 13, 2025

 

Sono-Tek Corporation

(Exact name of registrant as specified in its charter)

 

Commission File Number: 001-40763

 

New York   14-1568099
(State of Incorporation)   (I.R.S. Employer ID No.)
     
2012 Route 9W, Milton, New York   12547
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (845) 795-2020

 

Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading
Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value per share SOTK NASDAQ

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

Item 2.02: Results of Operations and Financial Condition.

Item 7.01: Regulation FD Disclosure

 

On October 13, 2025, Sono-Tek Corporation issued a press regarding an order for medical device coating systems valued at $2.8 Million which is attached as exhibit 99.1.

 

The information furnished pursuant to Item 2.02 and Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities under such section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.

 

Item 9.01: Financial Statements and Exhibits.

 

(d) Exhibits

 

99.1       Press release dated October 13, 2025

 

104        Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

SONO-TEK CORPORATION

 

By: /s/ Stephen J. Bagley

Stephen J. Bagley

Chief Financial Officer

October 13, 2025

 

 

FAQ

What did SOTK announce in this 8-K?

Sono-Tek announced a press release regarding an order for $2.8 million of medical device coating systems.

When was the announcement made?

The press release and 8-K are dated October 13, 2025.

Which items does the 8-K cover?

The 8-K furnishes information under Item 2.02 and Item 7.01.

Is the information considered filed with the SEC?

No. The information is furnished and is not deemed filed under Section 18 of the Exchange Act or incorporated by reference.

What exhibit accompanies the filing?

Exhibit 99.1, the press release dated October 13, 2025.

What is Sono-Tek's trading symbol and exchange?

The common stock trades on NASDAQ under the symbol SOTK.

Sono Tek Corp

NASDAQ:SOTK

SOTK Rankings

SOTK Latest News

SOTK Latest SEC Filings

SOTK Stock Data

64.87M
13.10M
16.21%
42.1%
0.03%
Scientific & Technical Instruments
Special Industry Machinery, Nec
Link
United States
MILTON